Study ID: MS-LAQ-301E | 2009-012989-30

Study Title

A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course

Teva Identifier

MS-LAQ-301E | 2009-012989-30

ClinicalTrials.gov Identifier

NCT00988052

Study Status

Terminated

Trial Condition(s)

Relapsing Multiple Sclerosis

Interventions

Drug: Laquinimod

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

November 10, 2009 - July 1, 2017

Phase

Phase 3

Study Type

Interventional